Control of Diabetes

Banting F. G. Best C. H. (1922). The internal secretion of the pancreas. J. Lab. clin. Med., 7, 251.

Bernhard H. (1965). Long-term observations on oral hypoglycaemic agents in diabetes. Diabetes, 14, 59.

Caird F. I. Garrett C. J. (1963). Prognosis for vision in diabetic retinopathy. Diabetes, 12, 389.

Chapman I. Cheung Wan Ho (1963). Pancytopaenia associated with Tolbutamide therapy. J. Amer. med. Ass., 186, 595.

Clarke B. F. Munro J. F. Duncan L. J. P. (1965). Time action studies and clinical trial of Actrapid and Crystall II Novo insulins. Brit. med. J., 2, 265.

Colwell J. A. (1966). Effect of diabetic control on retinopathy. Diabetes, 15, 497.

Dolger H. (1947). Clinical evaluation of vascular damage in diabetes mellitus. J. Amer. med. Ass., 134, 1289.

Dollery C. T. Oakley N. W. (1965). Reversal of retinal vascular changes in diabetes. Diabetes, 14, 121.

Downie E. Martin F. I. R. (1959). Vascular disease in juvenile diabetics of long duration. Diabetes, 8, 383.

Dunlop D. M. (1954). Are diabetic vascular complications preventable? Brit. med. J., 2, 383.

Hardin R. C. Jackson R. L. Johnson T. L. Kelly H. G. (1956). The development of diabetic retinopathy; effects of duration and control of diabetes. Diabetes, 5, 397.

Johnsson S. (1960). Retinopathy and nephropathy in diabetes mellitus. A comparison of two forms of treatment. Diabetes, 9, 1.

Keiding N. R. Root H. F. Marble A. (1952). Importance of control of diabetes in prevention of vascular complications. J. Amer. med. Ass., 150, 964.

Larsson Y. Lichtenstein A. Plowman K. G. (1952). Degenerative vascular complications in juvenile diabetes mellitus treated with ‘free diet’. Diabetes, 1, 449.

Lundbaek K. (1953). Long-term diabetes. Copenhagen: Ejnar Munksgaard and London & New York: Lange, Maxwell and Springer Ltd.

McMahon T. F. (1963). Cholestatic jaundice, liver decompensation and shock resulting from tolbutamide: Report of a case. Med. Ann. D.C., 32, 509.

Oakley W. Hill D. Oakley N. W. (1966). Combined use of regular and crystalline protamine (NPH) insulins in the treatment of severe diabetics. Diabetes, 15, 219.

Powell T. Howells L. (1966). Diabetes treated with Chlorpropamide and Tolbutamide. Diabetes, 15, 269.

Rooth G. Ostenson S. (1966). Acetone in alveolar air, and the control of diabetes. Lancet, 2, 1102.

Skouby A. P. (1956). Vascular lesions in diabetics with a special reference to the influence of treatment. Acta Med. scand., 155, Suppl. 117.

Spoont S. Dyer W. W. Day R. Blazer H. (1951). Incidence of diabetic retinopathy relative to the degree of diabetic control. Amer. J. med. Sci., 221, 490.

Stein J. H. Hamilton H. E. Sheets R. F. (1964). Agranulocytosis caused by Chlorpropamide. Case report with confirmation by leukoagglutination studies. Arch, intern. Med., 113, 186.

Stowers J. M. Bewsher P. D. (1962). The long-term use of sulphonylureas in diabetes mellitus. Lancet, 1, 122.

Stowers J. M. Helgason T. (1965). Trial of Chlorpropamide in subclincal diabetes. Diabetologia, 1, 128.

Unger R. H. Madison L. L. Carter N. W. (1960). Tolbutamide-Phenformin in ketoacidosis-resistant patients. J. Amer. med. Ass., 174, 2132.

Wilson J. L. Root H. F. Marble A. (1951). Prevention of degenerative vascular lesions in young patients by control of diabetes. Amer. J. med. Sci., 221, 479.